Study explorer (study characteristics and results) method abbreviations pdf   xlsx

display ongoing studies
Study Ref. Design studied treatmentcontrol treatmentpatientsstudy risk of biassample sizes Results

COVID 19 hospitalized meta-analysis

SAVE-MORE
 
NCT04680949
RCTanakinraplaceboCOVID 19 hospitalizedlow
412/194 conclusif
  • suggested 55 % decrease in deaths with a high degree of certainty due to low risk of bias
  • demonstrated 64 % decrease in clinical deterioration (PE) with a high degree of certainty due to low risk of bias

COVID-19 mild to moderate meta-analysis

CORIMUNO-ANA-1
 
NCT04341584
RCTanakinracontrolCOVID-19 mild to moderatesome concern
59/57 inconclusive

    PE: primary endpoint; (a): to be demonstrated a result must be statistically significant on a primary endpoint (with multiplicity adjustment if necessary);
    Study risk of bias assessed for the study primary endpoint(s) or the main endpoints in case of no formally defined primary endpoint(s).